https://www.selleckchem.com/pr....oducts/gsk1838705a.h
9% (AUC 0.64; p=0.043). Similar acute rejection rates were recorded in patients with mean ATP≥225 vs. 225ng/mL during the study period (7.1% vs. 9.1%, p=0.81). Although ImmuKnow® does not seem useful to predict non-CMV infection, it could identify patients with a very low risk and help us define a target for an optimal immunosuppression. Although ImmuKnow® does not seem useful to predict non-CMV infection, it could identify patients with a very low risk and help us define a target for an optimal immunosuppression. Recently, ther
Like
Comment
Share
